Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$99.8M |
| 2 |
Microsoft
MSFT
|
+$82.2M |
| 3 |
Pfizer
PFE
|
+$61.6M |
| 4 |
Colgate-Palmolive
CL
|
+$60M |
| 5 |
Amazon
AMZN
|
+$59.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$64.4M |
| 2 |
Huntington Ingalls Industries
HII
|
+$51.6M |
| 3 |
Darden Restaurants
DRI
|
+$44.7M |
| 4 |
Lowe's Companies
LOW
|
+$40.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$34.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.15% |
| 2 | Technology | 14.44% |
| 3 | Healthcare | 12.93% |
| 4 | Industrials | 11.21% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Idexx Laboratories
IDXX
$44.4B
| $57.4M | 0.06% |
489,161
+155,497
| +47% | +$17.7M |
2013 Q2
14 quarters
|
|
302
Loews
L
$22.4B
| $57.3M | 0.06% |
1,223,395
-181,665
| -13% | -$7.97M |
2013 Q2
14 quarters
|
|
303
Camden Property Trust
CPT
$11.4B
| $57M | 0.06% |
677,555
+29,008
| +4% | +$2.31M |
2013 Q2
14 quarters
|
|
304
Edwards Lifesciences
EW
$50B
| $56.7M | 0.06% |
1,815,018
-108,924
| -6% | -$3.53M |
2013 Q2
14 quarters
|
|
305
Newmont
NEM
$124B
| $56M | 0.06% |
1,644,918
-69,748
| -4% | -$2.38M |
2013 Q2
14 quarters
|
|
|
CXO
306
DELISTED
CONCHO RESOURCES INC.
CXO
| $56M | 0.06% |
421,946
+28,493
| +7% | +$3.87M |
2013 Q2
14 quarters
|
|
307
DTE Energy
DTE
$27B
| $55.8M | 0.06% |
665,112
+35,327
| +6% | +$2.84M |
2013 Q2
14 quarters
|
|
308
Illumina
ILMN
$39.8B
| $55.7M | 0.06% |
447,576
+17,532
| +4% | +$2.36M |
2013 Q2
14 quarters
|
|
309
Aptiv
APTV
$9.49B
| $55.5M | 0.06% |
824,063
+44,834
| +6% | +$3.01M |
2013 Q2
14 quarters
|
|
310
Dollar Tree
DLTR
$23.5B
| $54.9M | 0.06% |
711,400
+17,725
| +3% | +$1.43M |
2013 Q2
14 quarters
|
|
311
Northern Trust
NTRS
$30.3B
| $54.8M | 0.06% |
614,880
+20,872
| +4% | +$1.66M |
2013 Q2
14 quarters
|
|
312
VF Corp
VFC
$6.71B
| $54.5M | 0.06% |
1,084,819
+44,827
| +4% | +$2.32M |
2013 Q2
14 quarters
|
|
313
Xerox
XRX
$332M
| $54.3M | 0.06% |
2,359,051
+83,933
| +4% | +$2.09M |
2013 Q2
14 quarters
|
|
314
Diversified Healthcare Trust
DHC
$1.85B
| $54.1M | 0.06% |
2,855,455
+626,749
| +28% | +$12.1M |
2013 Q2
14 quarters
|
|
315
Regency Centers
REG
$13.4B
| $53.9M | 0.06% |
782,218
+25,224
| +3% | +$1.76M |
2013 Q2
14 quarters
|
|
316
Macy's
M
$6.37B
| $53.9M | 0.06% |
1,504,893
+73,007
| +5% | +$2.84M |
2013 Q2
14 quarters
|
|
317
Roper Technologies
ROP
$37.6B
| $53.7M | 0.06% |
293,534
+11,387
| +4% | +$2.04M |
2013 Q2
14 quarters
|
|
318
Western Union
WU
$1.92B
| $53.7M | 0.06% |
2,471,951
-52,646
| -2% | -$1.09M |
2013 Q2
14 quarters
|
|
319
DELISTED
Berry Global Group, Inc.
BERY
| $52.8M | 0.06% |
1,180,994
+155,684
| +15% | +$6.66M |
2013 Q2
14 quarters
|
|
320
Owens Corning
OC
$9.02B
| $52.5M | 0.06% |
1,017,341
+217,412
| +27% | +$11.3M |
2013 Q2
14 quarters
|
|
321
Monster Beverage
MNST
$89.9B
| $52.4M | 0.06% |
4,724,044
+132,628
| +3% | +$1.52M |
2013 Q2
14 quarters
|
|
322
Eversource Energy
ES
$25.2B
| $52.1M | 0.06% |
943,188
+45,267
| +5% | +$2.42M |
2013 Q2
14 quarters
|
|
|
NBL
323
DELISTED
Noble Energy, Inc.
NBL
| $51.9M | 0.06% |
1,363,534
+129,110
| +10% | +$4.8M |
2013 Q2
14 quarters
|
|
324
Vertex Pharmaceuticals
VRTX
$128B
| $51.3M | 0.06% |
695,831
+26,745
| +4% | +$2.18M |
2013 Q2
14 quarters
|
|
325
KLA
KLAC
$222B
| $51.2M | 0.06% |
6,507,930
+490,440
| +8% | +$3.75M |
2013 Q2
14 quarters
|
|
Similar funds
Charles Schwab's Q4 2016 Portfolio in Review
As of Q4 2016, Charles Schwab held 3,123 positions worth $91.3B, up 7.4% from $85.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.05B of net new capital in Q4 2016, opening 88 new positions and adding to 2,252 existing holdings. Its largest new stake was Howmet Aerospace: 1,721,382 shares worth $24.5M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Huntington Ingalls Industries, an estimated $51.6M trimmed.
- Charles Schwab's largest Q4 2016 buy was Howmet Aerospace: 1,721,382 shares worth $24.5M.
- Charles Schwab added most to Apple in Q4 2016, an estimated $99.8M increase.
- Charles Schwab's biggest Q4 2016 reduction was Huntington Ingalls Industries, cutting an estimated $51.6M.
- Charles Schwab fully exited DONNELLEY R R & SONS CO in Q4 2016, selling an estimated $64.4M.
- Charles Schwab's ten largest holdings make up 14% of its $91.3B portfolio in Q4 2016.
- Charles Schwab opened 88 new positions and closed 49 in Q4 2016.
- Charles Schwab's portfolio value rose 7.4% quarter-over-quarter to $91.3B.
Based on Charles Schwab's 13F filing for Q4 2016, filed 13 Feb 2017.